Table 3.
Cytochrome P450 2D6 genetic profiles, activity score and phenotypes in the retrospectively collected 38 samples from recurred patients
| Year | Genotype | Activity score | Phenotype | Year | Genotype | Activity score | Phenotype |
|---|---|---|---|---|---|---|---|
| 2015 | *2/*41 | 1.5 | NM | 2017 | *2/*10B | 1.25 | NM |
| 2015 | *10B /*21B | 0.25 | IM | 2017 | *10B/*10B | 0.5 | IM |
| 2015 | *1/*10B | 1.25 | NM | 2017 | *2/*10B | 1.25 | NM |
| 2015 | *10B/*10B | 0.5 | IM | 2017 | *10B/*10B | 0.5 | IM |
| 2015 | *1/*1 | 2 | NM | 2017 | *1/*10B | 1.25 | NM |
| 2015 | *2/*10B | 1.25 | NM | 2017 | *10B/*10B | 0.5 | IM |
| 2015 | *1/*10B | 1.25 | NM | 2017 | *10B/*10B | 0.5 | IM |
| 2016 | *1/*5 | 1 | IM | 2017 | *10B/*41 | 0.75 | IM |
| 2016 | *1/*5 | 1 | IM | 2017 | *2/*10B | 1.25 | NM |
| 2016 | *1/*1 | 2 | NM | 2018 | *10B/*52 | 0.5 | IM |
| 2016 | *5/*41 | 0.5 | IM | 2018 | *1/*10B | 1.25 | NM |
| 2016 | *5/*10B | 0.25 | IM | 2018 | *10B/*10B | 0.5 | IM |
| 2016 | *5/*10B | 0.25 | IM | 2018 | *2/*10B | 1.25 | NM |
| 2016 | *1/*10B | 1.25 | NM | 2018 | *10B/*10B | 0.5 | IM |
| 2016 | *1/*5 | 1 | IM | 2018 | *1/*2 | 2 | NM |
| 2016 | *10B/*10B | 0.5 | IM | 2018 | *1/*10B | 1.25 | NM |
| 2016 | *1/*5 | 1 | IM | 2018 | *4/*10B | 0.25 | IM |
| 2016 | *10B/*10B | 0.5 | IM | 2018 | *1/*5 | 1 | IM |
| 2016 | *1/*10B | 1.25 | NM | 2018 | *10B/*10B | 0.5 | IM |